Press release
Global Intranasal Drug Delivery Market to reach USD 104,248.63 million by 2032 at a CAGR of 6.24% by 2032, Evaluates DelveInsight
DelveInsight's "Intranasal Drug Delivery Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Intranasal Drug Delivery companies actively working in the market.
To know more about why North America is leading the market growth in the Intranasal Drug Delivery market, get a snapshot of the report Intranasal Drug Delivery Market Trends
https://www.delveinsight.com/sample-request/intranasal-drug-delivery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Intranasal Drug Delivery Overview
Intranasal drug delivery refers to the administration of medications through the nose, where drugs are absorbed by the nasal mucosa and enter the bloodstream. This route offers several advantages, including rapid onset of action, non-invasive administration, and the ability to bypass the digestive system and first-pass metabolism in the liver. It is commonly used for conditions such as migraines, allergies, pain management, hormonal therapies, and certain central nervous system disorders. Intranasal delivery is especially useful for patients who have difficulty swallowing or need fast-acting treatment.
DelveInsight Analysis: The intranasal drug delivery market size was worth USD 64,451.20 million in 2024 and is projected to expand at a CAGR of 6.24% between 2025 and 2032, ultimately reaching around USD 104,248.63 million by 2032.
Intranasal Drug Delivery Market Insights
Geographically, North America is projected to dominate the intranasal drug delivery market in 2024, largely due to the high burden of conditions such as neurological disorders, respiratory diseases, and diabetes, which are increasing the demand for fast-acting and user-friendly drug delivery methods. The growing preference for self-administered and quick-effect treatments is further accelerating the adoption of intranasal technologies in the region. In addition, frequent regulatory approvals and product launches from major pharmaceutical companies, along with strong healthcare infrastructure and higher patient awareness, are reinforcing the region's leadership in the global market.
To read more about the latest highlights related to Intranasal Drug Delivery, get a snapshot of the key highlights entailed in the Intranasal Drug Delivery Insights
https://www.delveinsight.com/report-store/intranasal-drug-delivery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Intranasal Drug Delivery Market Report
• In January 2025, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray. This approval makes SPRAVATO® the first and only monotherapy specifically indicated for adults with major depressive disorder (MDD) who have had an inadequate response to at least two oral antidepressants.
• In November 2024, Corxel Pharmaceuticals announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of the People's Republic of China (PRC) approved the New Drug Application (NDA) for varenicline solution nasal spray. This approval allowed the product to be marketed in China for the treatment of dry eye disease by increasing natural tear production, offering patients a novel, non-invasive therapeutic option.
• In August 2024, ARS Pharmaceuticals received FDA approval for neffy® (epinephrine nasal spray), marking a groundbreaking advancement as the first and only needle-free epinephrine treatment for Type I allergic reactions, including life-threatening anaphylaxis. This approval represented a significant milestone in allergy care, offering patients and caregivers a rapid, effective, and more accessible alternative to traditional auto-injectors.
• Thus, owing to such developments in the market, rapid growth will be observed in the Intranasal Drug Delivery market during the forecast period
Key Players in the Intranasal Drug Delivery Market
Some of the key market players operating in the Intranasal Drug Delivery market include- Pfizer Inc., Johnson & Johnson Services, Inc., EMERGENT, UCB S.A., GSK plc, Amphastar Pharmaceuticals, Inc., Neurelis, Inc., Hikma Pharmaceuticals PLC, Perrigo Company, ARS Pharmaceuticals Operations, Inc., AstraZeneca, Therakind, AFT Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Currax Pharmaceuticals LLC, Impel Pharmaceuticals LLC, Endo, Inc., Procter & Gamble, Teleflex Incorporated, Viatris, Inc., Amneal Pharmaceuticals LLC, and others.
Which MedTech key players in the Intranasal Drug Delivery market are set to emerge as the trendsetter explore @ Key Intranasal Drug Delivery Companies
https://www.delveinsight.com/sample-request/intranasal-drug-delivery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Intranasal Drug Delivery Market Landscape
As neurological disorders continue to rise worldwide, major pharmaceutical companies are ramping up R&D efforts to develop advanced intranasal spray formulations aimed at managing these conditions. A notable example is Pfizer's FDA approval in March 2023 for ZAVZPRETTM (zavegepant), a CGRP receptor-blocking nasal spray for the rapid treatment of migraine in adults. Likewise, in August 2023, Emergent BioSolutions introduced NARCAN® Naloxone HCl Nasal Spray 4 mg as an over-the-counter option for emergency opioid overdose reversal. These clinically significant approvals highlight the growing adoption of nasal sprays in both acute care and long-term disease management.
With rising therapeutic needs, continuous innovation, and supportive regulatory pathways, the nasal spray segment is expected to witness strong growth, contributing significantly to the expansion of the global intranasal drug delivery market.
Scope of the Intranasal Drug Delivery Market Report
• Coverage: Global
• Study Period: 2022-2032
• Intranasal Drug Delivery Market Segmentation By Dosage Form: Spray, Drops and Liquids, Gels, and Powders
• Intranasal Drug Delivery Market Segmentation By Container: Pressurized and Non-pressurized
• Intranasal Drug Delivery Market Segmentation By System: Unit-dose Systems, Bi-Dose Systems, and Multi-dose Systems
• Intranasal Drug Delivery Market Segmentation By Application: Respiratory Disorders, Neurological Disorders, Infectious Diseases, and Others
• Intranasal Drug Delivery Market Segmentation By Distribution Channel: Hospital & Retail Pharmacies and Online Pharmacies
• Intranasal Drug Delivery Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Intranasal Drug Delivery Companies: Pfizer Inc., Johnson & Johnson Services, Inc., EMERGENT, UCB S.A., GSK plc, Amphastar Pharmaceuticals, Inc., Neurelis, Inc., Hikma Pharmaceuticals PLC, Perrigo Company, ARS Pharmaceuticals Operations, Inc., AstraZeneca, Therakind, AFT Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Currax Pharmaceuticals LLC, Impel Pharmaceuticals LLC, Endo, Inc., Procter & Gamble, Teleflex Incorporated, Viatris, Inc., Amneal Pharmaceuticals LLC, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Intranasal Drug Delivery market will grow by 2032? Click to get a snapshot of the Intranasal Drug Delivery Market Analysis
https://www.delveinsight.com/sample-request/intranasal-drug-delivery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Intranasal Drug Delivery Market to reach USD 104,248.63 million by 2032 at a CAGR of 6.24% by 2032, Evaluates DelveInsight here
News-ID: 4255726 • Views: …
More Releases from DelveInsight Business Research
Global Clinical Trial Support Services Market to reach USD 43,160.56 million by …
According to DelveInsight's analysis, The clinical trial support services market is expanding swiftly, largely driven by the increasing incidence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases. This rise has resulted in a higher volume of clinical trials, greater R&D spending, and stronger investment in new drug development. Moreover, the growing collaboration among pharmaceutical, biotechnology, and medical device companies is boosting the need for specialized services, including regulatory…
Global Respiratory Inhalers Market to reach USD 51,132.25 million by 2032 at a C …
According to DelveInsight's analysis, The demand for respiratory inhalers is rising sharply, driven by a combination of factors. Chief among these is the increasing prevalence of respiratory disorders, including asthma, COPD, bronchitis, and bronchospasm, which continue to impact a growing global population and create a need for fast and effective treatments. Simultaneously, patient awareness regarding early diagnosis and consistent management of asthma and COPD is improving, further supporting market growth.…
Global Dysmenorrhea Treatment Market to reach USD 7,909.14 million by 2032 at a …
According to DelveInsight's analysis, The widespread occurrence of dysmenorrhea (menstrual pain), along with rising awareness and better diagnostic practices, is driving strong growth in the dysmenorrhea treatment market. As more women seek professional care for menstrual pain, the need for effective therapies from OTC painkillers to hormonal treatments continues to increase. Awareness initiatives and educational programs are also reducing stigma and promoting earlier treatment-seeking behavior. Meanwhile, leading companies are advancing…
Global Thrombectomy Devices Market to reach USD 2,806.85 million by 2032 at a CA …
According to DelveInsight's analysis, The increasing demand for thrombectomy devices is being propelled by several key factors contributing to robust market growth. The global rise in neurological and cardiovascular conditions such as acute ischemic stroke, pulmonary embolism, and deep vein thrombosis creates a critical need for timely and effective interventions. There is also a growing preference among patients and healthcare providers for minimally invasive treatment options. Additionally, ongoing innovations and…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
